Sirakoss Receives CE Mark For Osteo3 Synthetic Bone Graft Substitute
January 31, 2019
Represents New Hope for Repairing Challenging Bone Fractures Aberdeen, UK, January 31, 2019– SIRAKOSS Ltd, a developer of nanosynthetic bone graft substitutes to transform the